Log In
Print
BCIQ
Print
Print this Print this
 

Canmab, trastuzumab

  Manage Alerts
Collapse Summary General Information
Company Biocon Ltd.
DescriptionBiosimilar to trastuzumab
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionBinds HER2/neu; Antibody; Biosimilar
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today